AGIOS PHARMACEUTICALS, INC. Insider Trading for March 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for March 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 25,000 | 7,563 | 762,774 | |
| Mar 27 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 25,000 | 7,563 | 266,272 | 241.3 K to 266.3 K (+10.36 %) |
| Mar 20 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 80,000 | 24,200 | 286,040 | |
| Mar 20 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 80,000 | 24,200 | 209,090 | 129.1 K to 209.1 K (+61.97 %) |
| Mar 12 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 54,000 | 16,335 | 787,774 | |
| Mar 12 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 54,000 | 16,335 | 241,272 | 187.3 K to 241.3 K (+28.84 %) |
| Mar 12 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 20,000 | 6,050 | 366,040 | |
| Mar 12 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 20,000 | 6,050 | 129,090 | 109.1 K to 129.1 K (+18.33 %) |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.69 | 2,334 | 1,605 | 118,271 | |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.47 | 9,666 | 4,519 | 120,605 | |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.47 | 5,468 | 2,556 | 130,271 | |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | A | 31.64 | 40,000 | 1,265,600 | 135,739 | |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 45.10 | 12,000 | 541,200 | 0 | 12 K to 0 (-100.00 %) |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.69 | 2,334 | 1,605 | 12,000 | 9.7 K to 12 K (+24.15 %) |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.47 | 9,666 | 4,519 | 9,666 | 0 to 9.7 K |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 35.54 | 5,468 | 194,333 | 0 | 5.5 K to 0 (-100.00 %) |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.47 | 5,468 | 2,556 | 5,468 | 0 to 5.5 K |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | A | 31.64 | 80,000 | 2,531,200 | 320,090 | |
| Mar 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 8,000 | 2,420 | 320,686 | |
| Mar 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 29.85 | 8,000 | 238,832 | 109,090 | 117.1 K to 109.1 K (-6.83 %) |
| Mar 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 8,000 | 2,420 | 117,090 | 109.1 K to 117.1 K (+7.33 %) |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 9,000 | 2,723 | 386,040 | |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 5,646 | 1,708 | 395,040 | |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | A | 31.64 | 80,000 | 2,531,200 | 400,686 | |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 45.10 | 9,000 | 405,900 | 109,090 | 118.1 K to 109.1 K (-7.62 %) |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 9,000 | 2,723 | 118,090 | 109.1 K to 118.1 K (+8.25 %) |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 35.54 | 5,646 | 200,659 | 109,090 | 114.7 K to 109.1 K (-4.92 %) |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 5,646 | 1,708 | 114,736 | 109.1 K to 114.7 K (+5.18 %) |
| Mar 07 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | A | 31.64 | 160,000 | 5,062,400 | 841,774 | |
| Mar 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 6,000 | 2,805 | 240,090 | |
| Mar 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 29.85 | 6,000 | 179,124 | 0 | 6 K to 0 (-100.00 %) |
| Mar 04 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 6,000 | 2,805 | 6,000 | 0 to 6 K |